Marea Therapeutics

Marea Therapeutics

Biotechnology Research

San Francisco, CA 1,686 followers

The Next Frontier of Medicines for Cardiometabolic Diseases

About us

Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases. The company’s lead program, MAR001, is in Phase 2 clinical development and has the potential to become a new treatment for patients who remain at high risk of severe cardiovascular disease due to elevated remnant cholesterol and metabolic dysfunction. Marea is led by a dynamic team of scientists and company builders with deep know-how and experience in cardiometabolic diseases, human genetics and adipocyte biology.

Website
www.mareatx.com
Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
San Francisco, CA
Type
Privately Held

Locations

Employees at Marea Therapeutics

Updates

Similar pages

Funding